Trial intelligence / Profile preview

HP Acthar gel in idiopathic membranous nephropathy

NCT01093157Phase 2Completed

Sponsor
University Health Network
Start
Feb 2010
Primary completion
Jan 2013
Modality
Recombinant Proteins and Enzymes
Countries
1
01

Overview

A Phase 2 trial of repository corticotropin injection in membranous nephropathy (MN), sponsored by University Health Network. Started Feb 2010; status: completed.

02

Drugs

repository corticotropin injection
03

Conditions

membranous nephropathy (MN)

Beyond the preview

Go deeper on NCT01093157.

Study design, results and competitive context are available in the Gosset platform where reported.

Study design & results

Available in the Gosset platform where reported.

Competitive context

Available in the Gosset platform where reported.

Bring the full picture into focus.

See how Gosset can support your research on NCT01093157.

Gosset Free

Get started with Gosset.

Enter your corporate email.

Work email preferred.

Book a call